• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载氧化铁@聚多巴胺纳米颗粒的人脐带间充质干细胞通过促进海马神经发生改善阿尔茨海默病小鼠的认知功能。

FeO@polydopamine nanoparticle-loaded human umbilical cord mesenchymal stem cells improve the cognitive function in Alzheimer's disease mice by promoting hippocampal neurogenesis.

机构信息

Edmond H. Fischer Signal Transduction Laboratory, College of Life Sciences, Jilin University, Changchun, China.

Scientific Research Centre of China-Japan Union Hospital, Jilin University, Changchun, China.

出版信息

Nanomedicine. 2022 Feb;40:102507. doi: 10.1016/j.nano.2021.102507. Epub 2021 Dec 6.

DOI:10.1016/j.nano.2021.102507
PMID:34883265
Abstract

One of the most promising treatments for neurodegenerative diseases is the stem cell therapy; however, there are still some limitations in the treatment of Alzheimer's disease. In this study, superparamagnetic nanoparticles composed of magnetic FeO and polydopamine shells were used to label human umbilical cord mesenchymal stem cells (hUC-MSCs) in order to increase the targeting of hUC-MSCs. Our data suggested that FeO@PDA labeling increase the efficiency of hUC-MSCs entering the brain. Moreover, the water maze test showed that compared with hUC-MSCs only, FeO@PDA-labeled hUC-MSCs improved the cognitive ability of APP/PS1 transgenic mice more significantly. Other experimental data showed that the expression of essential proteins in the hippocampus, such as Aβ, synaptophysin, brain-derived neurotrophic factor, are affected by FeO@PDA coated-hUC-MSCs. The regulation of FeO@PDA coated-hUC-MSCs could improve the memory and cognitive ability of AD mice by excessive generation of neuroprotective factors, which might be considered a viable therapy to treat AD.

摘要

用于神经退行性疾病的最有前途的治疗方法之一是干细胞疗法;然而,阿尔茨海默病的治疗仍然存在一些局限性。在这项研究中,使用由磁性 FeO 和聚多巴胺壳组成的超顺磁纳米粒子来标记人脐带间充质干细胞(hUC-MSCs),以增加 hUC-MSCs 的靶向性。我们的数据表明,FeO@PDA 标记提高了 hUC-MSCs 进入大脑的效率。此外,水迷宫试验表明,与仅 hUC-MSCs 相比,FeO@PDA 标记的 hUC-MSCs 更显著地改善了 APP/PS1 转基因小鼠的认知能力。其他实验数据表明,海马中关键蛋白的表达,如 Aβ、突触小体蛋白、脑源性神经营养因子,受到 FeO@PDA 涂层-hUC-MSCs 的影响。FeO@PDA 涂层-hUC-MSCs 的调节可以通过过度产生神经保护因子来改善 AD 小鼠的记忆和认知能力,这可能被认为是治疗 AD 的一种可行疗法。

相似文献

1
FeO@polydopamine nanoparticle-loaded human umbilical cord mesenchymal stem cells improve the cognitive function in Alzheimer's disease mice by promoting hippocampal neurogenesis.载氧化铁@聚多巴胺纳米颗粒的人脐带间充质干细胞通过促进海马神经发生改善阿尔茨海默病小鼠的认知功能。
Nanomedicine. 2022 Feb;40:102507. doi: 10.1016/j.nano.2021.102507. Epub 2021 Dec 6.
2
Human umbilical cord mesenchymal stem cells transplantation improves cognitive function in Alzheimer's disease mice by decreasing oxidative stress and promoting hippocampal neurogenesis.人脐带间充质干细胞移植通过降低氧化应激和促进海马神经发生来改善阿尔茨海默病小鼠的认知功能。
Behav Brain Res. 2017 Mar 1;320:291-301. doi: 10.1016/j.bbr.2016.12.021. Epub 2016 Dec 19.
3
Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer's disease rats.脑源性神经营养因子修饰的人脐带间充质干细胞源性胆碱能样神经元可改善阿尔茨海默病大鼠的空间学习记忆能力。
Brain Res. 2019 May 1;1710:61-73. doi: 10.1016/j.brainres.2018.12.034. Epub 2018 Dec 23.
4
Resveratrol promotes hUC-MSCs engraftment and neural repair in a mouse model of Alzheimer's disease.白藜芦醇促进阿尔茨海默病小鼠模型中脐带间充质干细胞的植入和神经修复。
Behav Brain Res. 2018 Feb 26;339:297-304. doi: 10.1016/j.bbr.2017.10.032. Epub 2017 Nov 2.
5
MG53 protein rejuvenates hUC-MSCs and facilitates their therapeutic effects in AD mice by activating Nrf2 signaling pathway.MG53 蛋白通过激活 Nrf2 信号通路使 hUC-MSCs 恢复活力,并增强其在 AD 小鼠中的治疗效果。
Redox Biol. 2022 Jul;53:102325. doi: 10.1016/j.redox.2022.102325. Epub 2022 Apr 30.
6
Clinical-grade human umbilical cord-derived mesenchymal stem cells reverse cognitive aging via improving synaptic plasticity and endogenous neurogenesis.临床级人脐带间充质干细胞通过改善突触可塑性和内源性神经发生来逆转认知衰老。
Cell Death Dis. 2017 Aug 10;8(8):e2996. doi: 10.1038/cddis.2017.316.
7
Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats.植入人脐带间充质干细胞作为大鼠缺血性中风的神经保护疗法。
Brain Res. 2008 Sep 10;1229:233-48. doi: 10.1016/j.brainres.2008.06.087. Epub 2008 Jul 2.
8
FeO@Polydopamine-Labeled MSCs Targeting the Spinal Cord to Treat Neuropathic Pain Under the Guidance of a Magnetic Field.FeO@聚多巴胺标记的间充质干细胞靶向脊髓磁场引导治疗神经性疼痛
Int J Nanomedicine. 2021 May 11;16:3275-3292. doi: 10.2147/IJN.S296398. eCollection 2021.
9
Human umbilical cord-derived mesenchymal stem cells ameliorate perioperative neurocognitive disorder by inhibiting inflammatory responses and activating BDNF/TrkB/CREB signaling pathway in aged mice.人脐带间充质干细胞通过抑制炎症反应和激活 BDNF/TrkB/CREB 信号通路改善老年小鼠围手术期神经认知障碍。
Stem Cell Res Ther. 2023 Sep 21;14(1):263. doi: 10.1186/s13287-023-03499-x.
10
Co-Transplantation of Human Umbilical Cord Mesenchymal Stem Cells and Human Neural Stem Cells Improves the Outcome in Rats with Spinal Cord Injury.人脐带间充质干细胞与人神经干细胞共移植改善脊髓损伤大鼠的预后。
Cell Transplant. 2019 Jul;28(7):893-906. doi: 10.1177/0963689719844525. Epub 2019 Apr 23.

引用本文的文献

1
Therapeutic potential of mesenchymal stem cells in neurodegenerative diseases.间充质干细胞在神经退行性疾病中的治疗潜力。
World J Stem Cells. 2025 Aug 26;17(8):107717. doi: 10.4252/wjsc.v17.i8.107717.
2
Mesenchymal stem cell application in Alzheimer's disease.间充质干细胞在阿尔茨海默病中的应用。
Regen Ther. 2025 Jul 26;30:439-445. doi: 10.1016/j.reth.2025.07.006. eCollection 2025 Dec.
3
Investigating nanoparticle's utilization in stem cell therapy for neurological disorders.研究纳米颗粒在神经系统疾病干细胞治疗中的应用。
Am J Stem Cells. 2025 Apr 15;14(1):1-13. doi: 10.62347/YGYM4976. eCollection 2025.
4
Nanoparticle-Based Drug Delivery Systems Enhance Treatment of Cognitive Defects.基于纳米颗粒的药物传递系统增强认知缺陷的治疗效果。
Int J Nanomedicine. 2024 Nov 6;19:11357-11378. doi: 10.2147/IJN.S484838. eCollection 2024.
5
Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood-Brain Barrier Crossing Ability.有助于阿尔茨海默病诊断和治疗的纳米材料,解决血脑屏障穿透能力问题。
Adv Sci (Weinh). 2024 Oct;11(38):e2403473. doi: 10.1002/advs.202403473. Epub 2024 Aug 5.
6
Perinatal Tissue-Derived Stem Cells: An Emerging Therapeutic Strategy for Challenging Neurodegenerative Diseases.围产期组织来源的干细胞:治疗挑战性神经退行性疾病的新兴治疗策略。
Int J Mol Sci. 2024 Jan 12;25(2):976. doi: 10.3390/ijms25020976.
7
Cell primitive-based biomimetic nanomaterials for Alzheimer's disease targeting and therapy.用于阿尔茨海默病靶向治疗的基于细胞原代的仿生纳米材料。
Mater Today Bio. 2023 Sep 1;22:100789. doi: 10.1016/j.mtbio.2023.100789. eCollection 2023 Oct.
8
Inorganic nanoparticle-integrated mesenchymal stem cells: A potential biological agent for multifaceted applications.无机纳米颗粒整合的间充质干细胞:一种具有多方面应用潜力的生物制剂。
MedComm (2020). 2023 Jul 31;4(4):e313. doi: 10.1002/mco2.313. eCollection 2023 Aug.
9
Nanotherapeutic and Stem Cell Therapeutic Strategies in Neurodegenerative Diseases: A Promising Therapeutic Approach.神经退行性疾病的纳米治疗和干细胞治疗策略:一种有前途的治疗方法。
Int J Nanomedicine. 2023 Feb 3;18:611-626. doi: 10.2147/IJN.S395010. eCollection 2023.
10
Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer's disease: progress, advantages, and challenges.基于间充质干细胞和细胞外囊泡的阿尔茨海默病治疗方法:进展、优势与挑战
Neural Regen Res. 2023 Aug;18(8):1645-1651. doi: 10.4103/1673-5374.361546.